| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.670 | 1.347 | 1.218 | 1.559 | 1.971 | 1.242 | 1.414 | 2.984 | 2.782 | 5.275 |
| Total Income - EUR | 1.670 | 1.347 | 1.218 | 1.945 | 1.971 | 1.242 | 1.414 | 2.984 | 5.803 | 5.275 |
| Total Expenses - EUR | 705 | 858 | 440 | 1.565 | 1.530 | 2.206 | 1.818 | 2.823 | 5.504 | 5.062 |
| Gross Profit/Loss - EUR | 966 | 490 | 778 | 380 | 441 | -964 | -404 | 160 | 299 | 213 |
| Net Profit/Loss - EUR | 915 | 449 | 741 | 321 | 381 | -1.002 | -446 | 71 | 243 | 179 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biogrander S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 2.357 | 1.730 | 1.127 | 544 | 5.318 | 3.822 | 2.422 |
| Current Assets | 1.025 | 1.127 | 1.846 | 539 | 744 | 298 | 420 | 388 | 249 | 499 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 372 | 0 | 0 |
| Receivables | 0 | 0 | 1 | 24 | 14 | 19 | 18 | 0 | 55 | 159 |
| Cash | 1.025 | 1.127 | 1.845 | 515 | 730 | 279 | 402 | 16 | 193 | 340 |
| Shareholders Funds | 682 | 1.124 | 1.846 | 2.133 | 2.474 | 1.425 | 947 | 1.021 | 1.261 | 1.433 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 344 | 3 | 0 | 762 | 0 | 0 | 17 | 4.967 | 2.810 | 1.488 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4932 - 4932" | |||||||||
| CAEN Financial Year |
4932
|
|||||||||
Comments - Biogrander S.r.l.